Arathi R Setty1, Gary Curhan, Hyon K Choi. 1. Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass, USA.
Abstract
BACKGROUND: Psoriasis is a common, chronic, inflammatory skin disorder. Smoking may increase the risk of psoriasis, but no prospective data are available on this relation. METHODS: We prospectively examined over a 14-year time period (1991-2005) the relation between smoking status, duration, intensity, cessation, and exposure to secondhand smoke, and incident psoriasis in 78,532 women from the Nurses Health Study II. The primary outcome was incident, self-reported, physician-diagnosed psoriasis. RESULTS: We documented 887 incident cases of psoriasis. Compared with those who had never smoked, the multivariate relative risk (RR) of psoriasis was 1.78 (95% confidence interval [CI], 1.46 to 2.16) for current smokers and 1.37 (95% CI, 1.17 to 1.59) for past smokers. Compared with nonsmokers, the multivariate RR of psoriasis was 1.60 (95% CI, 1.31 to 1.97) for those who had smoked 11-20 pack-years and 2.05 (95% CI, 1.66 to 2.53) for those who had smoked > or =21 pack-years. Compared with never smokers, the multivariate RR of psoriasis was 1.61 (95% CI, 1.30 to 2.00) for those who quit smoking <10 years ago, 1.31 (95% CI, 1.05 to 1.64) for 10-19 years ago, and 1.15 (95% CI, 0.88 to 1.51) for > or =20 years ago. Prenatal and childhood exposure to passive smoke was associated with an increased risk of psoriasis. CONCLUSIONS: In this prospective analysis, current and past smoking, and cumulative measures of smoking were associated with the incidence of psoriasis. The risk of incident psoriasis among former smokers decreases nearly to that of never smokers 20 years after cessation.
BACKGROUND:Psoriasis is a common, chronic, inflammatory skin disorder. Smoking may increase the risk of psoriasis, but no prospective data are available on this relation. METHODS: We prospectively examined over a 14-year time period (1991-2005) the relation between smoking status, duration, intensity, cessation, and exposure to secondhand smoke, and incident psoriasis in 78,532 women from the Nurses Health Study II. The primary outcome was incident, self-reported, physician-diagnosed psoriasis. RESULTS: We documented 887 incident cases of psoriasis. Compared with those who had never smoked, the multivariate relative risk (RR) of psoriasis was 1.78 (95% confidence interval [CI], 1.46 to 2.16) for current smokers and 1.37 (95% CI, 1.17 to 1.59) for past smokers. Compared with nonsmokers, the multivariate RR of psoriasis was 1.60 (95% CI, 1.31 to 1.97) for those who had smoked 11-20 pack-years and 2.05 (95% CI, 1.66 to 2.53) for those who had smoked > or =21 pack-years. Compared with never smokers, the multivariate RR of psoriasis was 1.61 (95% CI, 1.30 to 2.00) for those who quit smoking <10 years ago, 1.31 (95% CI, 1.05 to 1.64) for 10-19 years ago, and 1.15 (95% CI, 0.88 to 1.51) for > or =20 years ago. Prenatal and childhood exposure to passive smoke was associated with an increased risk of psoriasis. CONCLUSIONS: In this prospective analysis, current and past smoking, and cumulative measures of smoking were associated with the incidence of psoriasis. The risk of incident psoriasis among former smokers decreases nearly to that of never smokers 20 years after cessation.
Authors: Joel M Gelfand; Steven R Feldman; Robert S Stern; John Thomas; Tara Rolstad; David J Margolis Journal: J Am Acad Dermatol Date: 2004-11 Impact factor: 11.527
Authors: Clinton S Robbins; David E Dawe; Susanna I Goncharova; Mahmoud A Pouladi; Anna G Drannik; Filip K Swirski; Gerard Cox; Martin R Stämpfli Journal: Am J Respir Cell Mol Biol Date: 2003-08-14 Impact factor: 6.914
Authors: Alexandra Aicher; Christopher Heeschen; Mariette Mohaupt; John P Cooke; Andreas M Zeiher; Stefanie Dimmeler Journal: Circulation Date: 2003-02-04 Impact factor: 29.690
Authors: Ann Bremander; Lennart T H Jacobsson; Stefan Bergman; Emma Haglund; Sofia Löfvendahl; Ingemar F Petersson Journal: Clin Rheumatol Date: 2014-07-15 Impact factor: 2.980
Authors: Ragna H Thorleifsdottir; Sigrun L Sigurdardottir; Bardur Sigurgeirsson; Jon H Olafsson; Hannes Petersen; Martin I Sigurdsson; Johann E Gudjonsson; Andrew Johnston; Helgi Valdimarsson Journal: J Am Acad Dermatol Date: 2016-08-09 Impact factor: 11.527
Authors: Wen-Qing Li; Eunyoung Cho; Martin A Weinstock; Hasan Mashfiq; Abrar A Qureshi Journal: Am J Public Health Date: 2016-07-26 Impact factor: 9.308